Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Ian Hardy
Individual Investor

Ian Hardy

Overview

Edit Overview Section
Number of Current Board & Advisor Roles 1
CB Rank (Investor) 302,920
  • Investor Type 
    obfuscation
Ian Hardy, PhD, MBA, Vice President of Chemistry, Manufacturing and Controls (CMC), Deerfield Discovery and Development at Deerfield Management.

Partner Investments

Edit Partner Investments Section
Number of Partner Investments 1
Announced Date  
Organization Name  
Investor Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Adaptive Phage Therapeutics Logo
Adaptive Phage Therapeutics
Deerfield Capital Management Logo
Deerfield Capital Management
Yes
Series B - Adaptive Phage Therapeutics Logo
Series B - Adaptive Phage Therapeutics
obfuscation

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 1
Ian Hardy is the Chairman at Adaptive Phage Therapeutics.

Recent News and Activity

Edit Recent News and Activity Section
There is no recent news or activity for this profile.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|